EUVIMEDEUVIMED entdecken
Open Access

Circulating microRNAs as molecular biomarkers for lung adenocarcinoma

Irina Robinson, Alexandra Bertsch, Katharina Leithner, Philipp Stiegler, Horst Olschewski, Andelko Hrzenjak

Cancer Biomarkers · 18.07.2022 · 34 (4) · 591-606

DOI: 10.3233/cbm-210205 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Biomarkers, erschienen am 18.07.2022. Verfasst von Irina Robinson und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Division of Pulmonology, Medical University of Graz, Graz, Austria. Hauptthemen laut MEDLINE: Adenocarcinoma of Lung, Circulating MicroRNA, Lung Neoplasms, MicroRNAs. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The potential of microRNAs (miRNAs) as molecular tumor biomarkers for early diagnosis and prognosis in lung cancer is still unclear. OBJECTIVE: To analyze expression of miRNAs in A549 lung adenocarcinoma (LUAD) cells and in primary, non-malignant bronchial epithelial (BE) cells from healthy donors. To analyze the most prominently deregulated miRNAs in plasma samples of LUAD patients and healthy donors. MATERIALS AND METHODS: The expression of 752 miRNAs in LUAD and BE cells was assessed by RT-qPCR with mean-centering restricted normalization. The relative plasma levels of 18 miRNAs in LUAD patients and healthy donors were analyzed using RT-qPCR and normalized to miR-191-5p and miR-16-3p. Putative interactions between miRNAs and their target genes were investigated in silico. RESULTS: Out of 752 miRNAs, 37 miRNAs were significantly deregulated in A549 cells compared to BE cells. MiR-15b-3p, miR-148a-3p, miR-193b-3p, and miR-195-5p were significantly deregulated in plasma samples of LUAD patients compared to donors. The target genes of those four miRNAs are involved in essential mechanisms in cancer development and progression. CONCLUSIONS: There are substantial differences between cancer and control miRNA expression in vitro and in plasma samples of LUAD patients compared to healthy donors. Four deregulated miRNAs are promising as a diagnostic biomarker for adenocarcinoma of the lung.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adenocarcinoma of LungCirculating MicroRNALung NeoplasmsMicroRNAsBiomarkers, TumorGene Expression Regulation, NeoplasticHumans

Stichwörter der Autor:innen

A549 cellsLung adenocarcinomabronchial epithelial cellsmicroRNAplasma samples

Substanzen

Biomarkers, TumorCirculating MicroRNAMicroRNAs

Autor:innen und Institutionen

  • Department of Internal Medicine, Division of Pulmonology, Medical University of Graz, Graz, Austria.
  • BioTechMed-Graz, Graz, Austria.
  • Division of Transplantation Surgery, Department of Surgery, Medical University of Graz, Graz, Austria.
  • Ludwig Boltzmann Institute for Lung Vascular Research, Medical University of Graz, Graz, Austria.

Zitieren

APA

Robinson, I., Bertsch, A., Leithner, K., Stiegler, P., Olschewski, H., & Hrzenjak, A. (2022). Circulating microRNAs as molecular biomarkers for lung adenocarcinoma. Cancer Biomarkers, 34(4), 591-606. https://doi.org/10.3233/cbm-210205

Vancouver

Robinson I, Bertsch A, Leithner K, Stiegler P, Olschewski H, Hrzenjak A. Circulating microRNAs as molecular biomarkers for lung adenocarcinoma. Cancer Biomarkers. 2022;34(4):591-606. doi:10.3233/cbm-210205

BibTeX
@article{Robinson2022,
  author = {Robinson, Irina and Bertsch, Alexandra and Leithner, Katharina and Stiegler, Philipp and Olschewski, Horst and Hrzenjak, Andelko},
  title = {Circulating microRNAs as molecular biomarkers for lung adenocarcinoma},
  journal = {Cancer Biomarkers},
  year = {2022},
  volume = {34},
  number = {4},
  pages = {591--606},
  doi = {10.3233/cbm-210205}
}
Kostenlos starten →